financetom
Business
financetom
/
Business
/
Atlassian Insider Sold Shares Worth $1,511,930, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atlassian Insider Sold Shares Worth $1,511,930, According to a Recent SEC Filing
May 8, 2024 2:44 PM

05:17 PM EDT, 05/08/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on May 07, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,511,930. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 292,281 shares of the company, with 292,281 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650372/000156218024003915/xslF345X03/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Newfold Digital to Sell Markmonitor to Com Laude
Newfold Digital to Sell Markmonitor to Com Laude
Sep 24, 2025
Transaction supports Newfold Digital's focus on core global brands, Bluehost and Network Solutions JACKSONVILLE, Fla., Sept. 24, 2025 /PRNewswire/ -- Newfold Digital, a leading web and commerce technology company serving nearly seven million customers globally, backed by Clearlake Capital Group, L.P. (together with affiliates, Clearlake) and Siris Capital Group (together with affiliates, Siris), today announced it has entered into an agreement...
CareTrust REIT Acquires Two Care Homes in the United Kingdom
CareTrust REIT Acquires Two Care Homes in the United Kingdom
Sep 24, 2025
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- CareTrust REIT, Inc. ( CTRE ) (“CareTrust” or the “Company”) announced today its acquisition of two care homes in the United Kingdom for approximately $27 million. The homes comprise 265 beds serving mostly higher acuity residents and are leased to an existing operator under long-term triple-net leases that include extension options and annual escalators. CareTrust funded...
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
Sep 24, 2025
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised terms Further Adjourns Special Meeting to October 3, 2025 SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 24, 2025 /PRNewswire/ -- ESSA Pharma Inc. ( EPIX ) (ESSA, or the Company) today announced that it has reached...
Form 8.3 - Dowlais Group PLC
Form 8.3 - Dowlais Group PLC
Sep 24, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved